Research programme: proteasome inhibitors - Eisai
Alternative Names: ER 807446; ER-804191; ER-805751Latest Information Update: 04 Jul 2007
At a glance
- Originator Eisai Co Ltd
- Class
- Mechanism of Action Apoptosis stimulants; Proteasome inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Apr 2004 Preclinical trials in Cancer in USA (unspecified route)